Overview
- 17 inspections across 16 sites are on record.
- 70 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-10-24.
At a glance
Inspections
17
Sites
16
Observations
70
Career since
Aug 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| CareFusion 213, LLC | 24 Oct 2025 | Human Drugs | On file |
| PCI San Diego, Inc. | 9 May 2025 | Human Drugs | View 483 → |
| Amgen, Inc. | 13 Mar 2025 | Human Drugs | On file |
| Nordmark Pharma GmbH | 13 Feb 2025 | Human Drugs | On file |
| Vet Pharma Friesoythe GmbH | 4 Feb 2025 | Animal Drugs & Feeds | On file |
Sites inspected
CareFusion 213, LLCEl Paso, United States1 insp.
PCI San Diego, Inc.San Diego, United States1 insp.
Amgen, Inc.Thousand Oaks, United States1 insp.
Nordmark Pharma GmbHUetersen, Germany1 insp.
Vet Pharma Friesoythe GmbHFriesoythe, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Nicholas L Hunt3 shared
Walden H Lee3 shared
Jose E Melendez2 shared
Homero W Aguilar2 shared
Crystal Monroy2 shared
Amir Alavi2 shared
Elvis Patel1 shared
Rodney L Tinzie1 shared
Rowena S Nguyen1 shared
Brittny C Cargo1 shared
Full investigator report
Get the verbatim findings behind Michael T Cyrus' 70 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site